Similarly, the role of IL-6 in cardiovascular disease is being actively investigated in ongoing clinical trials evaluating anti–IL-6 therapies in patients with coronary artery disease and chronic kidney disease [100]. Here, IL6 is linked to cardiovascular disorder.